Corporate Board Profile
Tech Score: 100/100
3 mention(s) identify ERIC WACHTER, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2021-04-29 | Eric A. Wachter, Ph.D., 58, has served as our Chief Technology Officer since May 2012. | Holds a Ph.D. in Chemistry and has experience in technology and pharmaceuticals, indicating a strong technical background. |
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2022-04-29 | Eric A. Wachter, Ph.D., 59, has served as our Chief Technology Officer since May 2012... He earned a Ph.D. in Chemistry from the University of Wisconsin–Madison in 1988. | Holds a Ph.D. in Chemistry and has served as Chief Technology Officer, indicating a strong technical background. |
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2024-05-06 | Eric A. Wachter, Ph.D., 60, has served as our Chief Technology Officer since May 2012. | Holds a Ph.D. in Chemistry and has served as Chief Technology Officer, indicating a strong technical background. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-29 | Eric A. Wachter, Ph.D., 58, has served as our Chief Technology Officer since May 2012. |
| 2022-04-29 | Eric A. Wachter, Ph.D., 59, has served as our Chief Technology Officer since May 2012... He earned a Ph.D. in Chemistry from the University of Wisconsin–Madison in 1988. |
| 2024-05-06 | Eric A. Wachter, Ph.D., 60, has served as our Chief Technology Officer since May 2012. |
Data sourced from SEC filings. Last updated: 2025-07-01